Language:
English
繁體中文
KMU OLIS
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Safety pharmacology in pharmaceutica...
~
Gad, Shayne C., (1948-)
Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Safety pharmacology in pharmaceutical development/ Shayne C. Gad.
Reminder of title:
approval and post marketing surveillance /
Author:
Gad, Shayne C.,
other author:
Gad, Shayne C.,
Published:
Boca Raton, FL :CRC Press, : c2012.,
[NT 15000922]:
2nd ed.
Description:
1 online resource (xv, 197 p.) :ill. :
Notes:
Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
基督教聖經之智慧書導讀 :
"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
Subject:
Drugs - Toxicology. -
Online resource:
http://www.crcnetbase.com/isbn/9781439845684
ISBN:
9781439845684 (electronic bk.)
Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /
Gad, Shayne C.,1948-
Safety pharmacology in pharmaceutical development
approval and post marketing surveillance /[electronic resource] :Shayne C. Gad. - 2nd ed. - Boca Raton, FL :CRC Press,c2012. - 1 online resource (xv, 197 p.) :ill.
Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
Includes bibliographical references and index.
Safety pharmacology: background, history, issues and concerns -- Regulatory requirements: ICH, FDA, EMA, and Japan -- Principles of screening and study design -- Cardiovascular system -- Central nervous system -- Respiratory system -- Renal function -- Gastrointestinal system -- Immune system.
"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
ISBN: 9781439845684 (electronic bk.)
LCCN: 2012009446Subjects--Topical Terms:
220299
Drugs
--Toxicology.
LC Class. No.: RA1238 / .G333 2012
Dewey Class. No.: 615.7/04
National Library of Medicine Call No.: 2012 F-386
Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /
LDR
:02030cam a2200325 a 4500
001
298208
003
OCoLC
005
20121015081754.0
006
m o d
007
cr |n|---|||||
008
161102s2012 flua ob 001 0 eng
010
$a
2012009446
020
$a
9781439845684 (electronic bk.)
020
$z
9781439845677 (hardback)
035
$a
(OCoLC)761380929
035
$a
761380929
040
$a
DNLM/DLC
$b
eng
$c
DLC
$d
YDX
$d
NLM
$d
UKMGB
$d
YDXCP
$d
OCLCO
$d
ZWZ
$d
CDX
$d
MXC
050
4
$a
RA1238
$b
.G333 2012
060
0 0
$a
2012 F-386
060
1 0
$a
QV 771
082
0 0
$a
615.7/04
$2
23
100
1
$2
97000
$a
Gad, Shayne C.,
$d
1948-
$3
255793
245
1 0
$a
Safety pharmacology in pharmaceutical development
$h
[electronic resource] :
$b
approval and post marketing surveillance /
$c
Shayne C. Gad.
250
$a
2nd ed.
260
$a
Boca Raton, FL :
$b
CRC Press,
$c
c2012.
300
$a
1 online resource (xv, 197 p.) :
$b
ill.
500
$a
Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
504
$a
Includes bibliographical references and index.
505
0
$a
Safety pharmacology: background, history, issues and concerns -- Regulatory requirements: ICH, FDA, EMA, and Japan -- Principles of screening and study design -- Cardiovascular system -- Central nervous system -- Respiratory system -- Renal function -- Gastrointestinal system -- Immune system.
520
$a
"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
588
$a
Description based on print version record.
650
0
$2
96060
$a
Drugs
$x
Toxicology.
$3
220299
650
0
$a
Drugs
$x
Safety measures.
$3
351601
650
0
$a
Drug development
$x
Safety measures.
$3
405217
650
1 2
$2
96060
$a
Drug Evaluation, Preclinical.
$3
253578
650
2 2
$2
96060
$a
Drug Approval.
$3
214022
650
2 2
$2
96060
$a
Product Surveillance, Postmarketing.
$3
254389
650
2 2
$a
Toxicity Tests.
$3
299491
700
1
$2
97000
$a
Gad, Shayne C.,
$d
1948-
$3
255793
856
4 0
$u
http://www.crcnetbase.com/isbn/9781439845684
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login